Census reports of many countries indicate continuing trends for the graying of their populations. For the United States alone, persons aged ≥65 years are projected to comprise over 20% of the population by the year 2050. In view of the special medical needs of elders, scientific investigation into the biological aspects of ageing is key towards the improvement of geriatric care for the coming decades. This special issue of Ageing Research Reviews focuses on advances in research on the immunology of human ageing. Herein are nine articles about the age-related alterations in both the innate and adaptive arms of the immune system, and about continuing hurdles in vaccinology. These articles point to a common theme that the immunological milieu in old age is substantially different from that seen in the young. This suggests that new development and/or innovation of immune-based clinical interventions for the elderly may need to be customized for their age group, rather than the mere adoption of therapies that have been designed for and/or tested for younger persons.
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Introduction: pandemic ageing of human populations
Since the latter half of the 20th century, many countries are witnessing the increased graying of their populations (UN-ESA, 2007) . Japan currently has the largest proportion of older adults aged ≥65 years at ∼23% that is projected to rise to ∼40% by the year 2050 (Japan Statistics Bureau, 2010) . For the United States, the current 12% of the population consisting of older adults is projected to also rise to 20% by the year 2050 (NCHS, 2010) . Similarly, older adults comprise 21% of the current population of the European Union, with Sweden and Italy having largest numbers of old people (Grant et al., 2004) . The elderly European population is projected to increase by 2050 at par with that of Japan due to phenomenal steady decline in birth rates for Japan and for the European Union member states (Grant et al., 2004; Japan Statistics Bureau, 2010) . Demographic shifts towards the increasing numbers of elderly persons are not exclusive to industrialized countries, but it is a global phenomenon (CIA, 2010) . Older adults are projected to comprise up to 25% and 15% of the aggregate population of developed and least developed countries, respectively, by 2050 (UN-ESA, 2005 ). Considering the myriad of age-related physiologic alterations, many of which are associated with age-related clinical syndromes (Stanziano et al., 2010) , and the projected steady rise in the cost of geriatric medical care irrespective of country (Rice and Fineman, 2004; Payne et al., 2007; van Elk et al., 2010) , ageing of the world population is a pandemic that present biomedical, socio-economic, and geo-political challenges.
Immunity and ageing: indispensability of human-based research
Immunity is a determinant of individual fitness, and the development of a diverse armamentarium of immune defenses is a modus operandi of speciation over millennia of evolution (McDade, 2003; McKean et al., 2008; Rosenstiel et al., 2009; Flajnik and Kasahara, 2010) . In higher chordates, immune defenses, like other physiological systems, undergo dramatic changes over the lifetime of the individual. Human neonates have very distinct immune physiology from that of adults (Zaghouani et al., 2009) , providing rationale for the traditional customization of immune interventions for infants and adolescents (de Brito et al., 2009) . It is now clear that the immune system undergoes even more dramatic changes beyond adolescence and sexual maturity. With the increasing numbers of elderly humans, research on the immunology of ageing is paramount more than ever to facilitate efforts for the improvement of the quality of life of elders for the coming decades.
Animal models, principally the various genetic strains of the laboratory mouse, have been advancing knowledge on the
